Breaking News Instant updates and real-time market news.

2022-04-11 08:07:33 BRP BRP Group $24.78 / -0.635 (-2.50%) , CB Chubb $216.04 / +3.595 (+1.69%) 08:07 04/11/22 04/11 08:07 04/11/22 08:07	BRP Group announces Richard Tallo as chief marketing officer BRP Group (BRP) announced Richard Tallo as chief marketing officer, effective immediately. In this role, Tallo will lead marketing and communications strategy across the firm, delivering programs designed to drive profitable growth and long-term brand recognition. Tallo joins BRP from Chubb (CB) where he served as executive VP, marketing and communications. BRP BRP Group $24.78 / -0.635 (-2.50%) CB Chubb $216.04 / +3.595 (+1.69%)	27 Apr 10 May 15 Sep

2022-04-11 08:07:33

BRP

BRP Group

$24.78 / -0.635 (-2.50%)

, CB

Chubb

$216.04 / +3.595 (+1.69%)

08:07

04/11/22

04/11

08:07

04/11/22

08:07

BRP Group announces Richard Tallo as chief marketing officer

BRP Group (BRP) announced Richard Tallo as chief marketing officer, effective immediately. In this role, Tallo will lead marketing and communications strategy across the firm, delivering programs designed to drive profitable growth and long-term brand recognition. Tallo joins BRP from Chubb (CB) where he served as executive VP, marketing and communications.

BRP

BRP Group

$24.78 / -0.635 (-2.50%)

Chubb

$216.04 / +3.595 (+1.69%)

27
Apr
10
May

15
Sep

OTHER BREAKING NEWS FROM THE FLY

Recommendations	New York Times share buys at UBS flagged by Gordon Haskett on activist link » 09:52 08/11/22 08/11 09:52 08/11/22 09:52 NYT New York Times $32.10 / +0.41 (+1.29%) , Z Zillow $39.61 / +0.34 (+0.87%) , ZG Zillow Group $39.75 / +0.445 (+1.13%) Gordon Haskett's… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NYT Z ZG NYT New York Times $32.10 / +0.41 (+1.29%) 08/03/22 New York Times sees FY22 CapEx approximately $55M 07/14/22 Hasbro, New York Times to launch new Wordle board game 06/13/22 New York Times announces midterm targets at investor day 05/04/22 New York Times sees FY22 capital expenditures $53M Z Zillow $39.61 / +0.34 (+0.87%) 08/04/22 Zillow, Opendoor announce multi-year partnership 05/05/22 Zillow drops 9% to $36.21 after Q2 revenue guidance misses estimates 05/05/22 Zillow Group falls over 9% to $35.27 after Q1 results, below-consensus guidance 05/05/22 Zillow Group board approves $1.0B buyback ZG Zillow Group $39.75 / +0.445 (+1.13%) 08/04/22 Zillow, Opendoor announce multi-year partnership 05/05/22 Zillow drops 9% to $36.21 after Q2 revenue guidance misses estimates 05/05/22 Zillow Group falls over 9% to $35.27 after Q1 results, below-consensus guidance 05/05/22 Zillow Group board approves $1.0B buyback NYT Z ZG NYT New York Times $32.10 / +0.41 (+1.29%) 08/04/22 Morgan Stanley New York Times price target lowered to $37 from $40 at Morgan Stanley 07/21/22 Guggenheim New York Times price target lowered to $34 from $41 at Guggenheim 06/22/22 Cannonball Research 'Not right market for' NYT story, Cannonball Research says in downgrade 06/22/22 Cannonball Research New York Times downgraded to Neutral from Buy at Cannonball Research Z Zillow $39.61 / +0.34 (+0.87%) 08/08/22 Stifel Zillow Group price target lowered to $37 from $40 at Stifel 08/05/22 Wedbush Zillow Group downgraded to Neutral on mortgage drag at Wedbush 08/05/22 Wedbush Zillow Group downgraded to Neutral from Outperform at Wedbush 08/05/22 Piper Sandler Zillow Group price target lowered to $31 from $39 at Piper Sandler ZG Zillow Group $39.75 / +0.445 (+1.13%) 08/08/22 Truist Zillow Group price target lowered to $37 from $41 at Truist 08/08/22 Stifel Zillow Group price target lowered to $37 from $40 at Stifel 08/05/22 RBC Capital Zillow Group price target lowered to $42 from $46 at RBC Capital 08/05/22 Canaccord Zillow Group price target lowered to $55 from $60 at Canaccord NYT Z ZG NYT New York Times $32.10 / +0.41 (+1.29%) 08/03/22 New York Times reports Q2 adjusted EPS 24c, consensus 19c 05/04/22 New York Times reports Q1 adjusted EPS 19c, consensus 18c Z Zillow $39.61 / +0.34 (+0.87%) 08/04/22 Zillow Group sees Q3 adjusted EBITDA $73M-$78M 08/04/22 Zillow Group reports Q2 adjusted EBITDA $164M vs $183M last year 08/04/22 Notable companies reporting after market close 05/05/22 Zillow Group sees Q2 revenue $903M-$1.03B, consensus $1.81B ZG Zillow Group $39.75 / +0.445 (+1.13%) 08/04/22 Zillow Group sees Q3 adjusted EBITDA $73M-$78M 08/04/22 Zillow Group reports Q2 adjusted EBITDA $164M vs $183M last year 08/04/22 Notable companies reporting after market close 05/05/22 Zillow Group sees Q2 revenue $903M-$1.03B, consensus $1.81B NYT Z ZG NYT New York Times $32.10 / +0.41 (+1.29%) 06/10/22 Facebook reviewing news deals, no indications of renewing, WSJ reports 06/08/22 Kara Swisher leaving New York Times for Vox Media, Bloomberg reports 04/07/22 NY Times' Baquet, in 'major shift,' makes Twitter presence 'optional,' WaPo says 03/08/22 New York Times removes news staff from Russia, NYT reports Z Zillow $39.61 / +0.34 (+0.87%) 07/30/22 Opendoor stock could double, Barron's says 04/14/22 Mortgage rates spike to 5% amid post-pandemic price pressures, NY Times says ZG Zillow Group $39.75 / +0.445 (+1.13%) 07/30/22 Opendoor stock could double, Barron's says NYT Z ZG NYT New York Times $32.10 / +0.41 (+1.29%) 06/13/22 What You Missed On Wall Street On Monday 06/13/22 What You Missed On Wall Street This Morning 03/08/22 What You Missed On Wall Street This Morning 03/04/22 What You Missed On Wall Street This Morning Z Zillow $39.61 / +0.34 (+0.87%) 08/05/22 What You Missed On Wall Street This Morning 08/04/22 Fly Intel: After-Hours Movers 05/06/22 What You Missed On Wall Street On Friday 05/06/22 What You Missed On Wall Street This Morning ZG Zillow Group $39.75 / +0.445 (+1.13%) 08/04/22 Fly Intel: After-Hours Movers 06/09/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/06/22 What You Missed On Wall Street On Friday 05/06/22 What You Missed On Wall Street This Morning 09/08/22 Consumer/Media/Entertainment Conference 08/23/22 Zillow Group Z Z Zillow $39.61 / +0.34 (+0.87%) 08/04/22 Zillow options imply 11.0% move in share price post-earnings 07/22/22 Zillow put volume heavy and directionally bearish 07/05/22 Zillow call volume above normal and directionally bullish 06/17/22 Unusually active option classes on open June 17th
Hot Stocks	Zhong Yang Financial Group Ltd trading resumes 09:50 08/11/22 08/11 09:50 08/11/22 09:50 TOP Top Financial $13.30 / +0.87 (+7.00%) ShowHide Related Items >><< Company News Syndicate On The Fly TOP Top Financial $13.30 / +0.87 (+7.00%) 09:37 Today Zhong Yang Financial Group Ltd trading halted, volatility trading pause 08/09/22 Zhong Yang Financial Group Ltd trading resumes 08/09/22 Zhong Yang Financial Group Ltd trading halted, volatility trading pause 08/08/22 Zhong Yang Financial Group Ltd trading resumes 01 Jun TOP Top Financial $13.30 / +0.87 (+7.00%) 06/25/22 Opening Day: Golden Sun rises in debut as Ivanhoe Electric delays IPO 06/04/22 Opening Day: Zhong Yang rises 240% in market debut
Hot Stocks	Alpha Teknova Inc trading resumes 09:49 08/11/22 08/11 09:49 08/11/22 09:49 TKNO Alpha Teknova $5.60 / -0.2 (-3.45%) ShowHide Related Items >><< Company News Street Research Earnings Events TKNO Alpha Teknova $5.60 / -0.2 (-3.45%) 09:44 Today Alpha Teknova Inc trading halted, volatility trading pause TKNO Alpha Teknova $5.60 / -0.2 (-3.45%) 06:34 Today Stephens Alpha Teknova price target lowered to $15 from $22 at Stephens 10/14/21 Cowen Alpha Teknova price target raised to $30 from $24 at Cowen TKNO Alpha Teknova $5.60 / -0.2 (-3.45%) 08/10/22 Alpha Teknova reports Q2 EPS (22c) vs. (52c) in last year's quarter 03/15/22 Alpha Teknova sees FY22 revenue $44M-$48M, consensus $42.04M 03/15/22 Alpha Teknova reports Q4 EPS (13c), consensus (17c) 02/28/22 Alpha Teknova sees Q4 revenue $10-$10.1M, consensus $8.45M 08/29/22 Med Tech & Life Sciences West Coast Field Trip
Recommendations	Haemonetics price target raised to $90 from $80 at JMP Securities » 09:48 08/11/22 08/11 09:48 08/11/22 09:48 HAE Haemonetics $74.08 / +0.5 (+0.68%) JMP Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings HAE Haemonetics $74.08 / +0.5 (+0.68%) 09:47 Today Haemonetics shares rose 9% on Wednesday following Q1 results 07/11/22 Axogen appoints William Burke to board of directors 06/24/22 Haemonetics completes move to manufacturing facility in Clinton, PA 05/10/22 Haemonetics rises 16.0% HAE Haemonetics $74.08 / +0.5 (+0.68%) 09:05 Today Barrington Haemonetics price target raised to $88 from $77 at Barrington 07/01/22 Morgan Stanley Haemonetics price target raised to $70 from $60 at Morgan Stanley 05/11/22 Barrington Haemonetics price target raised to $77 from $71 at Barrington 02/09/22 Barrington Haemonetics price target raised to $71 from $67 at Barrington HAE Haemonetics $74.08 / +0.5 (+0.68%) 05/10/22 Haemonetics sees 2023 adjusted EPS $2.50-$2.90, consensus $2.75 05/10/22 Haemonetics reports Q4 adjusted EPS 65c, consensus 60c
Hot Stocks	GSK plc falls -7.9% » 09:47 08/11/22 08/11 09:47 08/11/22 09:47 GSK GSK plc $35.26 / -3.055 (-7.97%) GSK plc is down -7.9%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GSK GSK plc $35.26 / -3.055 (-7.97%) 08/08/22 Mersana to get $100M upfront fee from GSK for co-commercialization of XMT-2056 08/08/22 GSK, IQVIA launch Vaccine Track platform 07/29/22 ViiV Healthcare presents five-year data at AIDS 2022 on fostemsavir 07/28/22 ViiV Healthcare announces data from unblinded phase of HPTN 084 study GSK GSK plc $35.26 / -3.055 (-7.97%) 08:34 Today Deutsche Bank Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank 08/09/22 Baird Mersana Therapeutics price target raised to $20 from $18 at Baird 08/08/22 UBS GSK plc price target lowered to 1,820 GBp from 1,860 GBp at UBS 08/05/22 Morgan Stanley GSK plc resumed with an Equal Weight at Morgan Stanley GSK GSK plc $35.26 / -3.055 (-7.97%) 07/27/22 GSK plc reports Q2 adjusted EPS 34.7p vs. 28.2p last year 04/27/22 GlaxoSmithKline reaffirms FY22 sales growth between 5%-7% at CER 04/27/22 GlaxoSmithKline reports Q1 adjusted EPS 32.8p vs. 22.9p last year 04/13/22 GlaxoSmithKline backs FY22 revenue view up 5%-7% at CER, consensus $47.34B GSK GSK plc $35.26 / -3.055 (-7.97%) 07:56 Today GSK, Sanofi weakness related to Zantac litigation worries, Bloomberg reports 07/18/22 GSK CEO says split will help deal with 'perennial underperformance,' FT reports 06/27/22 GSK's Haleon chooses Citi, UBS as spinoff brokers, Bloomberg says 06/27/22 GSK's Haleon chooses Citi, UBS as spinoff brokers, Bloomberg says GSK GSK plc $35.26 / -3.055 (-7.97%) 08/09/22 What You Missed On Wall Street On Tuesday 08/09/22 What You Missed On Wall Street This Morning 08/05/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/18/22 What You Missed On Wall Street This Morning 09/10/22 ESMO Congress 2022 GSK GSK plc $35.26 / -3.055 (-7.97%) 08/10/22 GSK plc (ADR) call volume above normal and directionally bullish 07/29/22 GSK plc (ADR) call volume above normal and directionally bullish 07/22/22 Two new option listings and one option delisting on July 22nd 07/20/22 One new option listing and two option delistings on July 20th
Hot Stocks	Six Flags falls -18.1% » 09:47 08/11/22 08/11 09:47 08/11/22 09:47 SIX Six Flags $21.11 / -4.695 (-18.19%) Six Flags is down -18.1%,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SIX Six Flags $21.11 / -4.695 (-18.19%) 08:04 Today Six Flags reports Q2 attendance 6.7M vs. 8.5M a year ago, down 22% 06:08 Today Six Flags drops 8% to $23.70 after Q2 results miss estimates 07/26/22 Novanta to replace Six Flags in the S&P 400 at open on 7/26 07/26/22 Six Flags to replace Natus Medical in the S&P 600 at open on 7/26 SIX Six Flags $21.11 / -4.695 (-18.19%) 07/08/22 Citi Six Flags downgraded to Neutral from Buy at Citi 06/24/22 Stifel Six Flags price target lowered to $35 from $52 at Stifel 06/21/22 B. Riley Six Flags downgraded to Neutral from Buy at B. Riley 05/13/22 Truist Six Flags price target lowered to $32 from $46 at Truist SIX Six Flags $21.11 / -4.695 (-18.19%) 06:00 Today Six Flags reports Q2 EPS 53c, consensus $1.02 08/10/22 Notable companies reporting before tomorrow's open 08/10/22 Notable companies reporting before tomorrow's open 05/12/22 Six Flags reports Q1 EPS (76c), consensus ($1.04) SIX Six Flags $21.11 / -4.695 (-18.19%) 08:51 Today Fly Intel: Pre-market Movers 07/21/22 Fly Intel: After-Hours Movers 07/08/22 What You Missed On Wall Street On Friday 07/08/22 What You Missed On Wall Street This Morning 08:00 Today Six Flags - SIX
Hot Stocks	Invitae falls -25.4% » 09:47 08/11/22 08/11 09:47 08/11/22 09:47 NVTA Invitae $6.44 / -2.3 (-26.32%) Invitae is down -25.4%,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options NVTA Invitae $6.44 / -2.3 (-26.32%) 09:42 Today Invitae trading resumes 09:37 Today Invitae trading halted, volatility trading pause 08/10/22 Invitae rises 46.1% 08/08/22 Cathie Wood's ARK Investment bought 813K shares of Invitae today NVTA Invitae $6.44 / -2.3 (-26.32%) 08/10/22 JPMorgan Invitae cut to Underweight at JPMorgan with future growth yet to be proven 08/10/22 JPMorgan Invitae downgraded to Underweight from Neutral at JPMorgan 07/26/22 Cowen Invitae cut to Market Perform at Cowen on debt refinancing uncertainty 07/26/22 Cowen Invitae downgraded to Market Perform from Outperform at Cowen NVTA Invitae $6.44 / -2.3 (-26.32%) 08/09/22 Invitae backs FY22 revenue growth of low double digits, consensus $542.96M 08/09/22 Invitae reports Q2 adjusted EPS (68c), consensus (76c) 07/18/22 Invitae sees second half of FY22 revenue flat over first half of FY22 07/18/22 Invitae sees Q2 revenue $136M, consensus $142.74M NVTA Invitae $6.44 / -2.3 (-26.32%) 08/10/22 What You Missed On Wall Street On Wednesday 08/10/22 What You Missed On Wall Street This Morning 07/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/18/22 Fly Intel: After-Hours Movers 09/10/22 ESMO Congress 2022 NVTA Invitae $6.44 / -2.3 (-26.32%) 08:00 Today Invitae call buyer realizes 3500% same-day gains 05/03/22 Invitae options imply 14.1% move in share price post-earnings 02/24/22 Invitae options imply 14.1% move in share price post-earnings
Hot Stocks	Haemonetics shares rose 9% on Wednesday following Q1 results » 09:47 08/11/22 08/11 09:47 08/11/22 09:47 HAE Haemonetics $74.08 / +0.5 (+0.68%) Shares of Haemonetics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings HAE Haemonetics $74.08 / +0.5 (+0.68%) 07/11/22 Axogen appoints William Burke to board of directors 06/24/22 Haemonetics completes move to manufacturing facility in Clinton, PA 05/10/22 Haemonetics rises 16.0% 03/21/22 Haemonetics names James D'Arecca CFO HAE Haemonetics $74.08 / +0.5 (+0.68%) 09:05 Today Barrington Haemonetics price target raised to $88 from $77 at Barrington 07/01/22 Morgan Stanley Haemonetics price target raised to $70 from $60 at Morgan Stanley 05/11/22 Barrington Haemonetics price target raised to $77 from $71 at Barrington 02/09/22 Barrington Haemonetics price target raised to $71 from $67 at Barrington HAE Haemonetics $74.08 / +0.5 (+0.68%) 05/10/22 Haemonetics sees 2023 adjusted EPS $2.50-$2.90, consensus $2.75 05/10/22 Haemonetics reports Q4 adjusted EPS 65c, consensus 60c
Hot Stocks	Solo Brands rises 14.7% » 09:47 08/11/22 08/11 09:47 08/11/22 09:47 DTC Solo Brands $6.96 / +0.97 (+16.19%) Solo Brands is up 14.7%,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options DTC Solo Brands $6.96 / +0.97 (+16.19%) 08/09/22 Solo Brands rises 14.2% 05/27/22 Solo Brands rises 19.5% 05/27/22 Solo Brands rises 13.2% 05/12/22 Solo Brands falls -15.0% DTC Solo Brands $6.96 / +0.97 (+16.19%) 08/02/22 Citi Solo Brands transferred with Buy rating at Citi 05/13/22 Citi Solo Brands price target lowered to $11 from $16 at Citi 03/30/22 Citi Solo Brands price target lowered to $16 from $20 at Citi 01/11/22 Citi Solo Brands upgraded to Buy from Neutral at Citi DTC Solo Brands $6.96 / +0.97 (+16.19%) 06:55 Today Solo Brands sees FY22 revenue growth in mid-20% range, consensus $548.76M 06:54 Today Solo Brands reports Q2 adjusted EPS 40c, consensus 28c 05/12/22 Solo Brands sees FY22 revenue $540M-$570M, consensus $556.7M 05/12/22 Solo Brands reports Q1 adjusted EPS 19c, consensus 8c 28 Oct DTC Solo Brands $6.96 / +0.97 (+16.19%) 05/21/22 Short Report: Bearish bets increase in meme names GameStop and Carvana 03/29/22 What You Missed On Wall Street On Tuesday 03/29/22 What You Missed On Wall Street This Morning 03/29/22 Fly Intel: Pre-market Movers 08:30 Today Solo Brands - DTC DTC Solo Brands $6.96 / +0.97 (+16.19%) 04/20/22 Five new option listings and one option delisting on April 20th
Hot Stocks	Dutch Bros rises 17.9% » 09:47 08/11/22 08/11 09:47 08/11/22 09:47 BROS Dutch Bros $52.33 / +8.27 (+18.77%) Dutch Bros is up 17.9%,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options BROS Dutch Bros $52.33 / +8.27 (+18.77%) 06/15/22 Dutch Bros CEO: Demand is not where we would like it to be 05/12/22 Dutch Bros falls -28.4% 05/12/22 Dutch Bros falls -40.1% 05/12/22 Dutch Bros falls -35.8% BROS Dutch Bros $52.33 / +8.27 (+18.77%) 06:31 Today Baird Dutch Bros price target raised to $46 from $30 at Baird 06:14 Today Piper Sandler Dutch Bros price target raised to $50 from $44 at Piper Sandler 07/11/22 Baird Dutch Bros downgraded to Neutral from Outperform at Baird 06/09/22 Barclays Dutch Bros price target raised to $34 from $25 at Barclays BROS Dutch Bros $52.33 / +8.27 (+18.77%) 08/10/22 Dutch Bros backs FY22 revenue view at least $715M, consensus $713.11M 08/10/22 Dutch Bros reports Q2 adjusted EPS 5c, consensus 7c 05/11/22 Dutch Bros sees FY22 revenue $700M-$715M, consensus $717.22M 05/11/22 Dutch Bros reports Q1 adjusted EPS (2c), consensus 1c 11 Mar 15 Sep BROS Dutch Bros $52.33 / +8.27 (+18.77%) 08/10/22 Fly Intel: After-Hours Movers 06/08/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/21/22 Short Report: Bearish bets increase in meme names GameStop and Carvana 05/12/22 What You Missed On Wall Street This Morning BROS Dutch Bros $52.33 / +8.27 (+18.77%) 08/10/22 Dutch Bros options imply 13.3% move in share price post-earnings 08/09/22 Dutch Bros put volume heavy and directionally bearish 07/29/22 Largest borrow rate increases among liquid names 07/11/22 Largest borrow rate increases among liquid names

Hot Stocks	Vizio rises 20.9% » 09:47 08/11/22 08/11 09:47 08/11/22 09:47 VZIO Vizio $12.62 / +2.23 (+21.46%) Vizio is up 20.9%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events VZIO Vizio $12.62 / +2.23 (+21.46%) 07/26/22 Vizio up 3% after Protocol report on Comcast acquisition talks 06/23/22 Vizio Smart TVs now integrated with Tik Tok TV 05/12/22 Vizio sees Q2 adjusted EBITDA $3M-$7M 04/26/22 Nielsen expands Smart TV data deal with Vizio VZIO Vizio $12.62 / +2.23 (+21.46%) 08/08/22 BofA Vizio price target lowered to $15 from $17 at BofA 07/22/22 JPMorgan Vizio price target lowered to $14 from $20 at JPMorgan 07/12/22 Guggenheim Vizio price target lowered to $12 from $14 at Guggenheim 05/13/22 Piper Sandler Vizio price target lowered to $15 from $21 at Piper Sandler VZIO Vizio $12.62 / +2.23 (+21.46%) 08/10/22 Vizio sees Q3 adjusted EBITDA $8M-$13M 08/10/22 Vizio reports Q2 EPS 1c vs (8c) last year 05/12/22 Vizio reports Q1 EPS (6c), consensus (5c) 03/03/22 Vizio sees Q1 adjusted EBITDA ($2M)-$2M VZIO Vizio $12.62 / +2.23 (+21.46%) 07/26/22 Comcast approached Vizio about potential acquisition, Protocol says VZIO Vizio $12.62 / +2.23 (+21.46%) 08/10/22 Fly Intel: After-Hours Movers 05/12/22 Fly Intel: After-Hours Movers 09/08/22 Consumer/Media/Entertainment Conference 08/17/22 Vizio 09/06/22 Vizio
Downgrade	Coupang downgraded to Hold from Buy at Deutsche Bank » 09:46 08/11/22 08/11 09:46 08/11/22 09:46 CPNG Coupang $20.61 / +0.89 (+4.51%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options CPNG Coupang $20.61 / +0.89 (+4.51%) 07/15/22 Coupang rises 7.9% 07/01/22 Coupang rises 13.4% 07/01/22 Coupang rises 9.1% 05/12/22 Coupang rises 24.8% CPNG Coupang $20.61 / +0.89 (+4.51%) 06:39 Today Mizuho Coupang price target raised to $22 from $18 at Mizuho 08/10/22 Macquarie Macquarie started Coupang at Outperform with $26 target yesterday 08/09/22 Macquarie Coupang initiated with an Outperform at Macquarie 06/30/22 Credit Suisse Coupang upgraded to Outperform at Credit Suisse following underperformance CPNG Coupang $20.61 / +0.89 (+4.51%) 08/10/22 Coupang raises FY22 adjusted EBITDA view 08/10/22 Coupang reports Q2 EPS (4c), consensus (11c) 05/11/22 Coupang reports Q1 EPS (12c), consensus (17c) 03/02/22 Coupang sees 2022 adjusted EBITDA loss less than ($400M) 14 Sep CPNG Coupang $20.61 / +0.89 (+4.51%) 03/28/22 Softbank's Alibaba shares in spotlight amid stock turbulence, WSJ reports CPNG Coupang $20.61 / +0.89 (+4.51%) 08/10/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/01/22 What You Missed On Wall Street On Friday 07/01/22 What You Missed On Wall Street This Morning 07/01/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations CPNG Coupang $20.61 / +0.89 (+4.51%) 08/10/22 Coupang options imply 10.6% move in share price post-earnings 07/20/22 Unusually active option classes on open July 20th 07/01/22 Coupang call volume above normal and directionally bullish 06/17/22 Coupang call volume above normal and directionally bullish
Hot Stocks	Main Street trading resumes 09:46 08/11/22 08/11 09:46 08/11/22 09:46 MAIN Main Street $44.86 / -0.005 (-0.01%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate MAIN Main Street $44.86 / -0.005 (-0.01%) 09:26 Today Main Street trading halted, news pending 08/02/22 Main Street raises dividend 2.3% to 66c 07/12/22 Main Street invests $19.5M in three market portfolio companies 04/14/22 Main Street originated $226.6M in new commitments in Q1 MAIN Main Street $44.86 / -0.005 (-0.01%) 08/08/22 Raymond James Main Street downgraded to Market Perform from Outperform at Raymond James 03/07/22 Hovde Group Main Street initiated with a Market Perform at Hovde Group 11/11/21 Truist Main Street price target raised to $43 from $40 at Truist 11/08/21 Raymond James Main Street price target raised to $47 from $44 at Raymond James MAIN Main Street $44.86 / -0.005 (-0.01%) 08/04/22 Main Street reports Q2 adjusted NII 78c, consensus 70c 05/05/22 Main Street reports Q1 NII 77c, consensus 70c 02/24/22 Main Street reports Q4 distribugtable NII 73c, consensus 65c 11 Aug
Hot Stocks	Veru trading resumes 09:44 08/11/22 08/11 09:44 08/11/22 09:44 VERU Veru $11.77 / -0.01 (-0.08%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options VERU Veru $11.77 / -0.01 (-0.08%) 09:39 Today Veru trading halted, volatility trading pause 08/09/22 Veru announces presentation of phase 3 study of Sabizabulin 07/27/22 Veru says EMA's ETF initiates review of sabizabulin for COVID-19 patients 07/25/22 Veru announces UK's MHRA supports expedited review of MAA for sabizabulin VERU Veru $11.77 / -0.01 (-0.08%) 08/03/22 Oppenheimer Oppenheimer says analysis provides context on Veru COVID Phase 3 mortality rates 07/06/22 Jefferies Veru data likely portend FDA authorization in 30 days, says Jefferies 05/18/22 Brookline Veru price target raised to $31 from $29 at Brookline 05/13/22 Jefferies Veru price target raised to $55 from $33 at Jefferies VERU Veru $11.77 / -0.01 (-0.08%) 06:45 Today Veru reports Q3 EPS (28c), consensus (18c) 05/12/22 Veru reports Q2 EPS (18c), consensus (15c) VERU Veru $11.77 / -0.01 (-0.08%) 07/08/22 Culper Research says short Veru, sees ' little to no hope of' sabizabulin EUA 05/02/22 Culper Research says shorting Veru, sees COVID-19 EUA as 'non-starter' 04/11/22 STAT's Feuerstein asks how 45% mortality rate 'possible' in Veru placebo arm VERU Veru $11.77 / -0.01 (-0.08%) 07/08/22 What You Missed On Wall Street On Friday 07/08/22 What You Missed On Wall Street This Morning 07/06/22 Fly Intel: After-Hours Movers 07/06/22 What You Missed On Wall Street On Wednesday 08:00 Today Veru - VERU VERU Veru $11.77 / -0.01 (-0.08%) 07/07/22 Veru call volume above normal and directionally bullish 06/27/22 Veru call volume above normal and directionally bullish 06/07/22 Veru call volume above normal and directionally bullish 06/07/22 Unusually active option classes on open June 7th
Hot Stocks	Alpha Teknova Inc trading halted, volatility trading pause 09:44 08/11/22 08/11 09:44 08/11/22 09:44 TKNO Alpha Teknova $5.80 / -0.005 (-0.09%) ShowHide Related Items >><< Street Research Earnings Events TKNO Alpha Teknova $5.80 / -0.005 (-0.09%) 06:34 Today Stephens Alpha Teknova price target lowered to $15 from $22 at Stephens 10/14/21 Cowen Alpha Teknova price target raised to $30 from $24 at Cowen TKNO Alpha Teknova $5.80 / -0.005 (-0.09%) 08/10/22 Alpha Teknova reports Q2 EPS (22c) vs. (52c) in last year's quarter 03/15/22 Alpha Teknova sees FY22 revenue $44M-$48M, consensus $42.04M 03/15/22 Alpha Teknova reports Q4 EPS (13c), consensus (17c) 02/28/22 Alpha Teknova sees Q4 revenue $10-$10.1M, consensus $8.45M 08/29/22 Med Tech & Life Sciences West Coast Field Trip
Recommendations	Plug Power price target raised to $36 from $20 at Citi » 09:43 08/11/22 08/11 09:43 08/11/22 09:43 PLUG Plug Power $28.77 / -0.01 (-0.03%) Citi analyst P.J. Juvekar… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PLUG Plug Power $28.77 / -0.01 (-0.03%) 08/04/22 New Fortress Energy enters 120MW green hydrogen plant deal with Plug Power 08/04/22 Plug Power selected by New Fortress Energy for 120 MW green hydrogen plant 07/29/22 Microsoft posts blog detailing work with partner Plug Power 07/12/22 Plug Power secures 5MW electrolyzer sale to Irving Oil PLUG Plug Power $28.77 / -0.01 (-0.03%) 09:25 Today Truist Plug Power price target raised to $32 from $21 at Truist 08/10/22 B. Riley Plug Power price target raised to $32 from $31 at B. Riley 08/10/22 Cowen Plug Power price target lowered to $35 from $44 at Cowen 08/10/22 BMO Capital Plug Power price target raised to $29 from $20 at BMO Capital PLUG Plug Power $28.77 / -0.01 (-0.03%) 08/09/22 Plug Power reports Q2 EPS (30c) vs. (18c) last year 08/09/22 Notable companies reporting after market close 05/09/22 Plug Power reports Q1 EPS (27c), consensus (16c) 05/09/22 Notable companies reporting after market close PLUG Plug Power $28.77 / -0.01 (-0.03%) 08/09/22 Fly Intel: After-Hours Movers 08/08/22 What You Missed This Week in EVs and Clean Energy 06/13/22 What You Missed This Week in EVs and Clean Energy 06/08/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/12/22 Annual Industrials, Energy & Airlines Conference PLUG Plug Power $28.77 / -0.01 (-0.03%) 07/28/22 Unusually active option classes on open July 28th 07/06/22 Plug Power call volume above normal and directionally bullish 06/27/22 Plug Power put volume heavy and directionally bearish 05/09/22 Unusually active option classes on open May 9th
Hot Stocks	Invitae trading resumes 09:42 08/11/22 08/11 09:42 08/11/22 09:42 NVTA Invitae $8.67 / -0.07 (-0.80%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options NVTA Invitae $8.67 / -0.07 (-0.80%) 09:37 Today Invitae trading halted, volatility trading pause 08/10/22 Invitae rises 46.1% 08/08/22 Cathie Wood's ARK Investment bought 813K shares of Invitae today 07/18/22 Invitae announces strategic business realignment NVTA Invitae $8.67 / -0.07 (-0.80%) 08/10/22 JPMorgan Invitae cut to Underweight at JPMorgan with future growth yet to be proven 08/10/22 JPMorgan Invitae downgraded to Underweight from Neutral at JPMorgan 07/26/22 Cowen Invitae cut to Market Perform at Cowen on debt refinancing uncertainty 07/26/22 Cowen Invitae downgraded to Market Perform from Outperform at Cowen NVTA Invitae $8.67 / -0.07 (-0.80%) 08/09/22 Invitae backs FY22 revenue growth of low double digits, consensus $542.96M 08/09/22 Invitae reports Q2 adjusted EPS (68c), consensus (76c) 07/18/22 Invitae sees second half of FY22 revenue flat over first half of FY22 07/18/22 Invitae sees Q2 revenue $136M, consensus $142.74M NVTA Invitae $8.67 / -0.07 (-0.80%) 08/10/22 What You Missed On Wall Street On Wednesday 08/10/22 What You Missed On Wall Street This Morning 07/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/18/22 Fly Intel: After-Hours Movers 09/10/22 ESMO Congress 2022 NVTA Invitae $8.67 / -0.07 (-0.80%) 08:00 Today Invitae call buyer realizes 3500% same-day gains 05/03/22 Invitae options imply 14.1% move in share price post-earnings 02/24/22 Invitae options imply 14.1% move in share price post-earnings
Periodicals	PPL share buys at UBS flagged at Dealreporter on bank's link to activists » 09:39 08/11/22 08/11 09:39 08/11/22 09:39 PPL PPL Corp. $29.01 / +0.515 (+1.81%) UBS, which has a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings PPL PPL Corp. $29.01 / +0.515 (+1.81%) 06/09/22 PPL Corp. increases common stock dividend to 22.5c from 20c per share 06/09/22 PPL Corp. management to provide update on strategic financial targets 05/25/22 PPL Corp. completes acquisition of Narragansett Electric from National Grid 05/23/22 PPL says Rhode Island court clears way for Narragansett Electric acquisition PPL PPL Corp. $29.01 / +0.515 (+1.81%) 07/14/22 Mizuho PPL Corp. price target lowered to $29 from $30 at Mizuho 07/07/22 Evercore ISI PPL Corp. upgraded to Outperform at Evercore ISI with re-rating expected 07/07/22 Evercore ISI PPL Corp. upgraded to Outperform from In Line at Evercore ISI 06/07/22 Wells Fargo PPL Corp. price target raised to $34 from $33 at Wells Fargo PPL PPL Corp. $29.01 / +0.515 (+1.81%) 08/03/22 PPL Corp. backs 2022 ongoing EPS view $1.30-$1.45, consensus $1.42 08/03/22 PPL Corp. reports Q2 ongoing EPS 30c, consensus 29c 05/05/22 PPL Corp. reports Q1 operating EPS 41c, consensus 39c 02/18/22 PPL Corp. reports Q4 adjusted EPS 22c, consensus 32c
Hot Stocks	Veru trading halted, volatility trading pause 09:39 08/11/22 08/11 09:39 08/11/22 09:39 VERU Veru $11.77 / +0.275 (+2.39%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options VERU Veru $11.77 / +0.275 (+2.39%) 08/09/22 Veru announces presentation of phase 3 study of Sabizabulin 07/27/22 Veru says EMA's ETF initiates review of sabizabulin for COVID-19 patients 07/25/22 Veru announces UK's MHRA supports expedited review of MAA for sabizabulin 07/08/22 Veru down 9% after Culper releases follow-up short report VERU Veru $11.77 / +0.275 (+2.39%) 08/03/22 Oppenheimer Oppenheimer says analysis provides context on Veru COVID Phase 3 mortality rates 07/06/22 Jefferies Veru data likely portend FDA authorization in 30 days, says Jefferies 05/18/22 Brookline Veru price target raised to $31 from $29 at Brookline 05/13/22 Jefferies Veru price target raised to $55 from $33 at Jefferies VERU Veru $11.77 / +0.275 (+2.39%) 06:45 Today Veru reports Q3 EPS (28c), consensus (18c) 05/12/22 Veru reports Q2 EPS (18c), consensus (15c) VERU Veru $11.77 / +0.275 (+2.39%) 07/08/22 Culper Research says short Veru, sees ' little to no hope of' sabizabulin EUA 05/02/22 Culper Research says shorting Veru, sees COVID-19 EUA as 'non-starter' 04/11/22 STAT's Feuerstein asks how 45% mortality rate 'possible' in Veru placebo arm VERU Veru $11.77 / +0.275 (+2.39%) 07/08/22 What You Missed On Wall Street On Friday 07/08/22 What You Missed On Wall Street This Morning 07/06/22 Fly Intel: After-Hours Movers 07/06/22 What You Missed On Wall Street On Wednesday 08:00 Today Veru - VERU VERU Veru $11.77 / +0.275 (+2.39%) 07/07/22 Veru call volume above normal and directionally bullish 06/27/22 Veru call volume above normal and directionally bullish 06/07/22 Veru call volume above normal and directionally bullish 06/07/22 Unusually active option classes on open June 7th
Conference/Events	Bayer to hold a showcase » 09:37 08/11/22 08/11 09:37 08/11/22 09:37 BAYRY Bayer $13.35 / +0.094 (+0.71%) Crop Science Field… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events BAYRY Bayer $13.35 / +0.094 (+0.71%) 08/05/22 FDA approves Bayer darolutamide tablets for prostate cancer 07/28/22 Ionis Pharmaceuticals announces 'positive' results from Phase 2b RE-THINC ESRD 07/05/22 Lyra Therapeutics appoints Nieman as Chief Medical Officer 06/28/22 Bayer's Kerendia recives new grade A recommendations from ADA BAYRY Bayer $13.35 / +0.094 (+0.71%) 07/20/22 Morgan Stanley Bayer price target raised to EUR 85 from EUR 83 at Morgan Stanley 06/13/22 Redburn FMC downgraded to Neutral on cost inflation at Redburn 05/19/22 UBS Bayer price target raised to EUR 96 from EUR 90 at UBS 05/11/22 Barclays Bayer price target raised to EUR 90 from EUR 85 at Barclays BAYRY Bayer $13.35 / +0.094 (+0.71%) 08/04/22 Bayer raises FY core EPS view to EUR7.30 vs. EUR7.00 previously 08/04/22 Bayer reports Q2 core EPS EUR1.93 vs. EUR1.61 last year 05/10/22 Bayer reports Q1 core EPS EUR 3.53 vs. EUR 2.59 last year 03/01/22 Bayer sees 2022 group sales of EUR 47B BAYRY Bayer $13.35 / +0.094 (+0.71%) 06/27/22 Supreme Court lets $87M award against Bayer for Roundup stand, Bloomberg reports 06/21/22 Supreme Court rejects Bayer bid to end Roundup suits, Bloomberg reports 05/11/22 Biden administration asks Supreme Court to reject Roundup appeal, Reuters says BAYRY Bayer $13.35 / +0.094 (+0.71%) 06/27/22 What You Missed On Wall Street On Monday 06/27/22 What You Missed On Wall Street This Morning 06/21/22 What You Missed On Wall Street On Tuesday 06/21/22 What You Missed On Wall Street This Morning 09/16/22 Biotech/Biopharma 09/10/22 ESMO Congress 2022 00:00 Today Bayer

Hot Stocks	Invitae trading halted, volatility trading pause 09:37 08/11/22 08/11 09:37 08/11/22 09:37 NVTA Invitae $8.67 / +6.39 (+280.26%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options NVTA Invitae $8.67 / +6.39 (+280.26%) 08/10/22 Invitae rises 46.1% 08/08/22 Cathie Wood's ARK Investment bought 813K shares of Invitae today 07/18/22 Invitae announces strategic business realignment 07/18/22 Invitae says Kenneth Knight to succeed Sean George as CEO NVTA Invitae $8.67 / +6.39 (+280.26%) 08/10/22 JPMorgan Invitae cut to Underweight at JPMorgan with future growth yet to be proven 08/10/22 JPMorgan Invitae downgraded to Underweight from Neutral at JPMorgan 07/26/22 Cowen Invitae cut to Market Perform at Cowen on debt refinancing uncertainty 07/26/22 Cowen Invitae downgraded to Market Perform from Outperform at Cowen NVTA Invitae $8.67 / +6.39 (+280.26%) 08/09/22 Invitae backs FY22 revenue growth of low double digits, consensus $542.96M 08/09/22 Invitae reports Q2 adjusted EPS (68c), consensus (76c) 07/18/22 Invitae sees second half of FY22 revenue flat over first half of FY22 07/18/22 Invitae sees Q2 revenue $136M, consensus $142.74M NVTA Invitae $8.67 / +6.39 (+280.26%) 08/10/22 What You Missed On Wall Street On Wednesday 08/10/22 What You Missed On Wall Street This Morning 07/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/18/22 Fly Intel: After-Hours Movers 09/10/22 ESMO Congress 2022 NVTA Invitae $8.67 / +6.39 (+280.26%) 08:00 Today Invitae call buyer realizes 3500% same-day gains 05/03/22 Invitae options imply 14.1% move in share price post-earnings 02/24/22 Invitae options imply 14.1% move in share price post-earnings
Hot Stocks	Zhong Yang Financial Group Ltd trading halted, volatility trading pause 09:37 08/11/22 08/11 09:37 08/11/22 09:37 TOP Top Financial $12.58 / -2.61 (-17.18%) ShowHide Related Items >><< Company News Syndicate On The Fly TOP Top Financial $12.58 / -2.61 (-17.18%) 08/09/22 Zhong Yang Financial Group Ltd trading resumes 08/09/22 Zhong Yang Financial Group Ltd trading halted, volatility trading pause 08/08/22 Zhong Yang Financial Group Ltd trading resumes 08/08/22 Zhong Yang Financial Group Ltd trading halted, volatility trading pause 01 Jun TOP Top Financial $12.58 / -2.61 (-17.18%) 06/25/22 Opening Day: Golden Sun rises in debut as Ivanhoe Electric delays IPO 06/04/22 Opening Day: Zhong Yang rises 240% in market debut
Hot Stocks	Red Robin trading resumes 09:36 08/11/22 08/11 09:36 08/11/22 09:36 RRGB Red Robin $10.65 / +0.85 (+8.67%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly RRGB Red Robin $10.65 / +0.85 (+8.67%) 09:31 Today Red Robin trading halted, volatility trading pause 08/10/22 Red Robin cuts FY22 adjusted EBITDA view to at least $65M from $80M-$90M 08/10/22 Red Robin reports Q2 SSS up 6.7% y/y and up 4.1% from 2019 07/14/22 Red Robin names G.J. Hart as CEO RRGB Red Robin $10.65 / +0.85 (+8.67%) 06:32 Today Benchmark Red Robin downgraded to Hold from Buy at Benchmark 06:18 Today Benchmark Red Robin downgraded to Hold from Buy at Benchmark 04/18/22 Raymond James Red Robin downgraded to Market Perform from Outperform at Raymond James 04/18/22 Raymond James Red Robin downgraded to Market Perform from Outperform at Raymond James RRGB Red Robin $10.65 / +0.85 (+8.67%) 08/10/22 Red Robin reports Q2 EPS (75c) vs. (22c) last year 05/26/22 Red Robin reports Q1 EPS (12c), consensus (73c) 03/10/22 Red Robin reports Q4 EPS ($1.36), consensus (53c) RRGB Red Robin $10.65 / +0.85 (+8.67%) 08/10/22 Fly Intel: After-Hours Movers 07/14/22 Fly Intel: After-Hours Movers 06/06/22 Fly Intel: Pre-market Movers 05/26/22 Fly Intel: After-Hours Movers
Recommendations	Village Farms price target lowered to $6 from $10 at Alliance Global Partners » 09:35 08/11/22 08/11 09:35 08/11/22 09:35 VFF Village Farms $2.88 / +0.025 (+0.88%) Alliance Global Partners… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings VFF Village Farms $2.88 / +0.025 (+0.88%) 08/09/22 Village Farms announces Leli Holland been granted tenth cannabis license 07/19/22 Pure Sunfarms launches The Original Fraser Valley Weed Co. 05/03/22 Village Farms' Pure Sunfarms, NOYA bring Cookies sun-grown flower to Ontario 04/20/22 Pure Sunfarms launches Pure Sunfarms FLOWERHOOD VFF Village Farms $2.88 / +0.025 (+0.88%) 08/09/22 Craig-Hallum Craig-Hallum downgrades Village Farms, sees shares being 'range-bound' 08/09/22 Craig-Hallum Village Farms downgraded to Hold from Buy at Craig-Hallum 05/11/22 Craig-Hallum Village Farms price target lowered to $5 from $15 at Craig-Hallum 05/11/22 Raymond James Village Farms downgraded to Outperform from Strong Buy at Raymond James VFF Village Farms $2.88 / +0.025 (+0.88%) 08/09/22 Village Farms reports Q2 EPS (41c) vs. (13c) last year 05/10/22 Village Farms reports Q1 EPS (7c), consensus (1c) 03/01/22 Village Farms reports Q4 EPS 3c, consensus 2c
Hot Stocks	NeoGames SA trading resumes 09:35 08/11/22 08/11 09:35 08/11/22 09:35 NGMS Neogames $17.74 / +0.625 (+3.65%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options NGMS Neogames $17.74 / +0.625 (+3.65%) 09:30 Today NeoGames SA trading halted, volatility trading pause 06/28/22 Neogames announces agreement with Intralot do Brasil 04/19/22 Neogames files annual report on Form 20-F NGMS Neogames $17.74 / +0.625 (+3.65%) 03/31/22 Jefferies Neogames initiated with a Buy at Jefferies 03/11/22 Truist Neogames price target lowered to $30 from $33 at Truist 01/13/22 Truist Neogames price target lowered to $33 from $50 at Truist NGMS Neogames $17.74 / +0.625 (+3.65%) 05/11/22 Neogames seesFY22 revenue $91M-$96M, consensus $93.16M 05/11/22 Neogames seesFY22 revenue $91M-$96M, consensus $93.16M 05/11/22 Neogames reports Q1 EPS 3c, consensus 9c 03/09/22 Neogames sees FY22 revenue $90M-$97M, consensus $94.18M 14 Sep NGMS Neogames $17.74 / +0.625 (+3.65%) 03/31/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/09/22 Fly Intel: After-Hours Movers 08:30 Today Neogames - NGMS NGMS Neogames $17.74 / +0.625 (+3.65%) 04/29/22 Fourteen new option listings and one option delisting on April 29th

Events

Earnings calls, analyst events, roadshows and more

HUT
Today at 10:00

Hut 8 Mining - HUT Conference Calls
ZEAL
Today at 10:00

Zealand Pharma - ZEAL Conference Calls
EYE
Today at 10:00

National Vision - EYE Conference Calls
BAM
Today at 10:00

Brookfield - BAM Conference Calls
PTNR
Today at 10:00

Partner Communications - PTNR Conference Calls
HSON
Today at 10:00

Hudson Global - HSON Conference Calls
SOHO
Today at 10:00

Sotherly Hotels - SOHO Conference Calls
SLNG
Today at 10:00

Stabilis Energy - SLNG Conference Calls
PRMW
Today at 10:00

Primo Water - PRMW Conference Calls
GPRK
Today at 10:00

GeoPark - GPRK Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	AYTU X AYTU Aytu BioPharma Spot Secondary Managers: Cantor Fitzgerald & Canaccord Priced at: $0.43 21.5M Shares BRBR X BRBR BellRing Brands Spot Secondary Managers: JPMorgan, Barclays, Citi, Goldman Sachs & Morgan Stanley Priced at: $23.50 14.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDNA X MDNA Medicenna Therapeutics Spot Secondary Managers: Guggenheim, Bloom Burton Securities Priced at: $1.50 13.333M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NUZE X NUZE NuZee Spot Secondary Managers: Maxim Priced at: $0.82 4.2M Shares PFLT X PFLT PennantPark Floating Rate Spot Secondary Managers: Morgan Stanley, Goldman Sachs, JPMorgan, Keefe Bruyette, RBC Capital & Truist Priced at: $12.40 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan, Jefferies Priced at: $215.00 3.49M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MIRM X MIRM Mirum Pharmaceuticals Spot Secondary Managers: JPMorgan, SVB Securities & Evercore ISI, Raymond James Priced at: $23.00 3.48M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TDW X TDW Tidewater Spot Secondary Managers: Morgan Stanley Priced at: $17.85 3.52M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	ATNX X ATNX Athenex Secondary Managers: SVB Securities Priced at: $.75 35.3M Shares CINC X CINC CinCor Pharma Secondary Managers: Goldman Sachs, Morgan Stanley, Jefferies & Piper Sandler Priced at: $30.00 7.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EVTC X EVTC Evertec Secondary Managers: JPMorgan Priced at: $32.00 6.26M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LXU X LXU LSB Industries Secondary Managers: Goldman Sachs & UBS, Deutsche Bank, Jefferies, Piper Sandler, RBC Capital, BNP Paribas, Stifel Priced at: $13.00 13.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SOVO X SOVO Sovos Brands Secondary Managers: JPMorgan & Goldman Sachs, BofA, Credit Suisse, Barclays, UBS, Cowen, Piper Sandler, Stifel, William Blair, Telsey Advisory, Drexel Hamilton, Loop Capital Priced at: $14.00 8.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRNA X VRNA Verona Pharma Secondary Managers: Jefferies, Piper Sandler & Truist Priced at: $10.50 12.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNL X BNL Broadstone Net Lease Spot Secondary Managers: Goldman Sachs, BMO Capital, JPMorgan & Truist Priced at: $21.35 13M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KIDS X KIDS OrthoPediatrics Spot Secondary Managers: Piper Sandler & Stifel Priced at: $55.00 750K Shares
Thurs	TGL X TGL Treasure Global IPO Managers: EF Hutton Priced at: $4.00 2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	BIAF X BIAF Bioaffinity Technologies IPO Managers: WallachBeth $6.00-6.25 1.285M Shares
Wed	MAIN X MAIN Main Street Spot Secondary Managers: RBC Capital, UBS & Wells Fargo $42.65-43.30 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	FRZA X FRZA Forza X1 IPO Managers: ThinkEquity $5.00 3M Shares CERE X CERE Cerevel Therapeutics Secondary Managers: Morgan Stanley, Goldman Sachs, Jefferies & Evercore ISI, Loop Capital, Seibert Williams $41.42 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PTLO X PTLO Portillo's Secondary Managers: Jefferies & Morgan Stanley, BofA, Piper Sandler $28.44 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RANI X RANI Rani Therapeutics Secondary Managers: BofA, Cantor Fitzgerald & UBS, BTIG, H.C. Wainwright $11.11
Fri	No deals

View All Syndicate Announcements »

BRP Group announces Richard Tallo as chief marketing officer

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access